The Effect of Magnesium on Post-spinal Headaches
The Effect of Intravenous Magnesium Sulphate on the Development of Post-Spinal Headache Following Caesarean Section Under Spinal Anaesthesia: A Retrospective Cohort Study
This retrospective cohort study aims to assess the effect of the use of magnesium sulphate in routine clinical practice on the development of post-dural puncture headache in patients undergoing spinal anaesthesia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Sultangazi
-
Istanbul, Sultangazi, Turkey (Türkiye)
- Haseki Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
In this study, which is designed as a retrospective cohort study, the records of all patients who underwent caesarean section under spinal anaesthesia at our hospital between 1 January 2025 and 31 December 2025 and who met the inclusion criteria will be reviewed.
Description
Inclusion Criteria:
-
• Patients aged 18-45
- Patients who underwent spinal anaesthesia for elective caesarean section
- Patients with an ASA physical status score of I-III
- Patients in whom a 25G or 27G pencil-point needle was used for spinal anaesthesia
- Patients with complete medical records
Exclusion Criteria:
-
• Patients undergoing emergency surgery
- Patients with a history of chronic headaches
- Patients who have undergone unsuccessful spinal anaesthesia or multiple attempts
- Patients who have undergone combined spinal-epidural anaesthesia
- Patients with a contraindication to magnesium sulphate
- Patients with insufficient medical records
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: RETROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
administered intravenous magnesium
|
Post-spinal headache in patients receiving magnesium |
|
without intravenous magnesium
|
Post-spinal headache in patients receiving magnesium |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of post-spinal headache
Time Frame: 1. day
|
the number of people who develop a headache following spinal anaesthesia |
1. day
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Uppal V, Russell R, Sondekoppam R, Ansari J, Baber Z, Chen Y, DelPizzo K, Dirzu DS, Kalagara H, Kissoon NR, Kranz PG, Leffert L, Lim G, Lobo CA, Lucas DN, Moka E, Rodriguez SE, Sehmbi H, Vallejo MC, Volk T, Narouze S. Consensus Practice Guidelines on Postdural Puncture Headache From a Multisociety, International Working Group: A Summary Report. JAMA Netw Open. 2023 Aug 1;6(8):e2325387. doi: 10.1001/jamanetworkopen.2023.25387.
- Alatni RI, Alsamani R, Alqefari A. Treatment and Prevention of Post-dural Puncture Headaches: A Systematic Review. Cureus. 2024 Jan 15;16(1):e52330. doi: 10.7759/cureus.52330. eCollection 2024 Jan.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MG-260326
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.